drugset
drugset / Trial / NCT03308110

Bioavailability and Food Effect Study of Two Formulations of PF-06650833

NCT03308110 ↗

Phase 1 Completed 24 enrolled Pfizer
CrossoverOpen-labelOther

Summary

Bioavailability and food effect of 2 formulations of PF-06650833 in healthy volunteers.

Timeline

Start
2017-09-08
Primary completion
2017-12-08
Completion
2018-01-11

Drugs

EvaluationDrugModalityDoseRoute
Subject ZIMLOVISERTIB Small molecule — —

Indications

No indication recorded.